Parallel Advisors, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 160 filers reported holding HERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.49 and the average weighting 0.7%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$206
-78.4%
200
-75.7%
0.00%
Q2 2023$955
-23.2%
8230.0%0.00%
Q1 2023$1,243
+148.6%
823
+311.5%
0.00%
Q4 2022$500
-50.0%
2000.0%0.00%
Q3 2022$1,0000.0%2000.0%0.00%
Q2 2022$1,0000.0%2000.0%0.00%
Q1 2022$1,000
-50.0%
2000.0%0.00%
Q4 2021$2,0000.0%2000.0%0.00%
Q3 2021$2,000
-33.3%
2000.0%0.00%
Q2 2021$3,0000.0%2000.0%0.00%
Q1 2021$3,000
-25.0%
2000.0%0.00%
Q4 2020$4,000
+33.3%
2000.0%0.00%
Q3 2020$3,000
-25.0%
200
-37.9%
0.00%
Q2 2020$4,000
+100.0%
322
+61.0%
0.00%
Q1 2020$2,000
-95.1%
200
-88.1%
0.00%
-100.0%
Q1 2019$41,000
+241.7%
1,685
+247.4%
0.01%
+150.0%
Q4 2018$12,000
+200.0%
485
+94.0%
0.00%
+100.0%
Q2 2017$4,000
-50.0%
250
-50.0%
0.00%0.0%
Q1 2017$8,000
+166.7%
500
+100.0%
0.00%0.0%
Q4 2016$3,0002500.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders